Trial Details
RECRUITINGBasic Information
| Clinical ID | c1685 |
|---|---|
| Identifier | NCT06663332 |
| Trial Title | A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohns Disease|Colitis, Ulcerative|Arthritis, Psoriatic|Arthritis, Juvenile |
| Interventions | DRUG: Guselkumab |
Participant Information
| Sponsor | Janssen Research & Development, LLC |
|---|---|
| City | Salt Lake City |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2024-10-29 |
|---|---|
| Primary Completion Date | 2031-12-12 |
| Completion Date | 2031-12-12 |